This is an incredibly important subject. I agree with the substance of what the hon. Lady asked in the question, and she is quite right to raise this. We have put in place the new variant assessment platform, allowing any country around the world to use our enormous genomic sequencing capability if they want to sequence positive cases to discover what is happening in their countries, but our borders testing system, in which all positives are sequenced, also means that we in fact get a survey from around the world through those who have travelled to the UK, and we can relay that data back to individual countries so that they understand that better. Of course, it would be far better if something like the new variant assessment platform was run on a multilateral basis globally—for instance, by an organisation such as the WHO. We are engaged with the WHO on making sure that it is available, but my view was that we needed to get on and offer this to everybody and then build a network of labs around the world that can make such an offer so that sequencing can be available in every country, because it is currently far too patchy.
Covid-19 Update
Proceeding contribution from
Matt Hancock
(Conservative)
in the House of Commons on Monday, 19 April 2021.
It occurred during Ministerial statement on Covid-19 Update.
About this proceeding contribution
Reference
692 c664 Session
2019-21Chamber / Committee
House of Commons chamberSubjects
Librarians' tools
Timestamp
2021-04-20 13:02:56 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2021-04-19/21041917000015
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2021-04-19/21041917000015
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2021-04-19/21041917000015